ALPORT SYNDROME

Clinical trials for ALPORT SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ALPORT SYNDROME trials appear

Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Completed 5 Terminated 1

Drug combo shows promise to slow kidney failure in rare genetic disease

Disease control Ongoing

This study tests whether two common kidney drugs, dapagliflozin and spironolactone, can lower protein in the urine of adults with Alport syndrome, a genetic condition that often leads to kidney failure. About 34 participants will try each drug alone and then both together for sho…

Matched conditions: ALPORT SYNDROME

Phase: PHASE4 • Sponsor: Stefan Lujinschi • Aim: Disease control

Last updated May 11, 2026 20:38 UTC

ALPORT SYNDROME

Get alerted when new ALPORT SYNDROME trials appear

Drug combo shows promise to slow kidney failure in rare genetic disease